{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:04:56Z","timestamp":1774551896898,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87535-1","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:59:01Z","timestamp":1738612741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis drug development"],"prefix":"10.1038","volume":"15","author":[{"given":"Katharina","family":"Weinh\u00e4upl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Meuret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Desrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Roussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Morellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Beaupierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"van Heijenoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Abian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatos","family":"Akopian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Krandor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Velazquez-Campoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Gauto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"87535_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ab.2018.12.004","volume":"567","author":"H Fraga","year":"2019","unstructured":"Fraga, H. et al. Development of high throughput screening methods for inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis. Anal. Biochem. 567, 30\u201337 (2019).","journal-title":"Anal. Biochem."},{"key":"87535_CR2","doi-asserted-by":"publisher","first-page":"102503","DOI":"10.1016\/j.jbc.2022.102553","volume":"298","author":"K Weinh\u00e4upl","year":"2022","unstructured":"Weinh\u00e4upl, K. et al. Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action. J. Biol. Chem. 298, 102503 (2022).","journal-title":"J. Biol. Chem."},{"key":"87535_CR3","doi-asserted-by":"publisher","first-page":"1002511","DOI":"10.1371\/journal.ppat.1002511","volume":"8","author":"RM Raju","year":"2012","unstructured":"Raju, R. M. et al. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection. PLoS Pathog. 8, 1002511 (2012).","journal-title":"PLoS Pathog."},{"key":"87535_CR4","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1074\/jbc.M114.625640","volume":"290","author":"T Akopian","year":"2015","unstructured":"Akopian, T. et al. Cleavage specificity of Mycobacterium tuberculosis ClpP1P2 protease and identification of novel peptide substrates and boronate inhibitors with anti-bacterial activity. J. Biol. Chem. 290, 11008\u201311020 (2015).","journal-title":"J. Biol. Chem."},{"key":"87535_CR5","doi-asserted-by":"publisher","first-page":"30883","DOI":"10.1074\/jbc.M113.493767","volume":"288","author":"D Vasudevan","year":"2013","unstructured":"Vasudevan, D., Rao, S. P. S. & Noble, C. G. Structural basis of mycobacterial inhibition by Cyclomarin A. J. Biol. Chem. 288, 30883\u201330891 (2013).","journal-title":"J. Biol. Chem."},{"key":"87535_CR6","doi-asserted-by":"publisher","first-page":"11273","DOI":"10.1021\/ja992482o","volume":"121","author":"MK Renner","year":"1999","unstructured":"Renner, M. K. et al. Cyclomarins A-C, new antiinflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). J. Am. Chem. Soc. 121, 11273\u201311276 (1999).","journal-title":"J. Am. Chem. Soc."},{"key":"87535_CR7","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1002\/anie.201101740","volume":"50","author":"EK Schmitt","year":"2011","unstructured":"Schmitt, E. K. et al. The natural product cyclomarin kills mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. Angew. Chem. Int. Ed. 50, 5889\u20135891 (2011).","journal-title":"Angew. Chem. Int. Ed."},{"key":"87535_CR8","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1074\/jbc.RA118.002251","volume":"293","author":"K Weinh\u00e4upl","year":"2018","unstructured":"Weinh\u00e4upl, K. et al. The antibiotic cyclomarin blocks arginine-phosphate\u2013induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis. J. Biol. Chem. 293, 8379\u20138393 (2018).","journal-title":"J. Biol. Chem."},{"key":"87535_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1107\/S2059798320004027","volume":"76","author":"NM Wolf","year":"2020","unstructured":"Wolf, N. M. et al. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions. Acta Crystallogr. D Struct. Biol. 76, 458\u2013471 (2020).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"87535_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/AAC.04054-14","volume":"59","author":"W Gao","year":"2015","unstructured":"Gao, W. et al. The cyclic peptide ecumicin targeting CLpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrob. Agents Chemother. 59, 880\u2013889 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"87535_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"E Gavrish","year":"2014","unstructured":"Gavrish, E. et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 21, 509\u2013518 (2014).","journal-title":"Chem. Biol."},{"key":"87535_CR12","doi-asserted-by":"publisher","first-page":"126771","DOI":"10.1016\/j.ijbiomac.2023.126771","volume":"253","author":"MK Jagdev","year":"2023","unstructured":"Jagdev, M. K. et al. Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin. Int. J. Biol. Macromol. 253, 126771 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"87535_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/acsinfecdis.8b00276","volume":"5","author":"NM Wolf","year":"2019","unstructured":"Wolf, N. M. et al. High-resolution structure of ClpC1-rufomycin and ligand binding studies provide a framework to design and optimize anti-tuberculosis leads. ACS Infect. Dis. 5, 829\u2013840 (2019).","journal-title":"ACS Infect. Dis."},{"key":"87535_CR14","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1021\/acs.joc.8b00988","volume":"83","author":"MP Choules","year":"2018","unstructured":"Choules, M. P. et al. Residual complexity does impact organic chemistry and drug discovery: The case of rufomyazine and rufomycin. J. Organ. Chem. 83, 6664\u20136672 (2018).","journal-title":"J. Organ. Chem."},{"key":"87535_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1128\/AAC.02204-18","volume":"63","author":"MP Choules","year":"2019","unstructured":"Choules, M. P. et al. Rufomycin targets clpc1 proteolysis in mycobacterium tuberculosis and M. Abscessus. Antimicrob. Agents Chemother. 63, 18 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"87535_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cmdc.201500346","volume":"10","author":"A Hillisch","year":"2015","unstructured":"Hillisch, A., Heinrich, N. & Wild, H. Computational chemistry in the pharmaceutical industry: From childhood to adolescence. ChemMedChem 10, 1958\u20131962 (2015).","journal-title":"ChemMedChem"},{"key":"87535_CR17","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1021\/acs.jmedchem.5b00294","volume":"58","author":"DA Erlanson","year":"2015","unstructured":"Erlanson, D. A. Learning from PAINful lessons. J. Med. Chem. 58, 2088\u20132090 (2015).","journal-title":"J. Med. Chem."},{"key":"87535_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s43586-023-00199-x","volume":"3","author":"M Bastos","year":"2023","unstructured":"Bastos, M. et al. Isothermal titration calorimetry. Nat. Rev. Methods Primers 3, 17 (2023).","journal-title":"Nat. Rev. Methods Primers"},{"key":"87535_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1021\/np8006292","volume":"72","author":"M Litaudon","year":"2009","unstructured":"Litaudon, M. et al. A dimeric sesquiterpenoid from a Malaysian Meiogyne as a new inhibitor of Bcl-xL\/BakBH3 domain peptide interaction. J. Nat. Prod. 72, 480\u2013483 (2009).","journal-title":"J. Nat. Prod."},{"key":"87535_CR20","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.cell.2022.05.009","volume":"185","author":"FE Morreale","year":"2022","unstructured":"Morreale, F. E. et al. BacPROTACs mediate targeted protein degradation in bacteria. Cell 185, 2338-2353.e18 (2022).","journal-title":"Cell"},{"key":"87535_CR21","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.cell.2023.04.009","volume":"186","author":"DM Hoi","year":"2023","unstructured":"Hoi, D. M. et al. Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival. Cell 186, 2176-2192.e22 (2023).","journal-title":"Cell"},{"key":"87535_CR22","doi-asserted-by":"publisher","first-page":"46218","DOI":"10.1038\/s41467-024-46218-7","volume":"15","author":"L Junk","year":"2024","unstructured":"Junk, L. et al. Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria. Nat. Commun. 15, 46218 (2024).","journal-title":"Nat. Commun."},{"key":"87535_CR23","first-page":"528552","volume":"2023","author":"HI Won","year":"2023","unstructured":"Won, H. I. et al. Chemically-induced targeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy. Biorxiv 2023, 528552 (2023).","journal-title":"Biorxiv"},{"key":"87535_CR24","doi-asserted-by":"publisher","first-page":"100904","DOI":"10.1016\/j.rechem.2023.100904","volume":"5","author":"A Bhanot","year":"2023","unstructured":"Bhanot, A. et al. Discovery of small molecule inhibitors of Mycobacterium tuberculosis ClpC1: SAR studies and antimycobacterial evaluation. Results Chem. 5, 100904 (2023).","journal-title":"Results Chem."},{"key":"87535_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu, J. et al. Ultra-large library docking for discovering new chemotypes. Nature 566, 224\u2013229 (2019).","journal-title":"Nature"},{"key":"87535_CR26","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/ejoc.201201628","volume":"2013","author":"J Dardenne","year":"2013","unstructured":"Dardenne, J., Desrat, S., Gu\u00e9ritte, F. & Roussi, F. Asymmetric synthesis of two analogues of meiogynin A. Eur. J. Org. Chem. 2013, 2116\u20132122 (2013).","journal-title":"Eur. J. Org. Chem."},{"key":"87535_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejmech.2018.01.100","volume":"148","author":"A Abou Samra","year":"2018","unstructured":"Abou Samra, A. et al. Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A. Eur. J. Med. Chem. 148, 26\u201338 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"87535_CR28","unstructured":"AI is a viable alternative to high throughput screening: A 318-target study. Sci. Rep. 14, 7526 (2024)."},{"key":"87535_CR29","doi-asserted-by":"crossref","unstructured":"O\u2019Boyle, N. M. et al. Open babel: An open chemical toolbox. J. Cheminform. 3 (2011).","DOI":"10.1186\/1758-2946-3-33"},{"key":"87535_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"87535_CR31","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1039\/C4CC01830C","volume":"50","author":"S Desrat","year":"2014","unstructured":"Desrat, S. et al. From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins. Chem. Commun. 50, 8593 (2014).","journal-title":"Chem. Commun."},{"key":"87535_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph Model 25, 247\u2013260 (2006).","journal-title":"J. Mol. Graph Model"},{"key":"87535_CR33","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer, R., G\u00f6tz, A. W., Poole, D., Le Grand, S. & Walker, R. C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh ewald. J. Chem. Theory Comput. 9, 3878\u20133888 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"87535_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1021\/ct200909j","volume":"8","author":"AW G\u00f6tz","year":"2012","unstructured":"G\u00f6tz, A. W. et al. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J. Chem. Theory Comput. 8, 1542\u20131555 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"87535_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cpc.2012.09.022","volume":"184","author":"S Le Grand","year":"2013","unstructured":"Le Grand, S., G\u00f6tz, A. W. & Walker, R. C. SPFP: Speed without compromise\u2014A mixed precision model for GPU accelerated molecular dynamics simulations. Comput. Phys. Commun. 184, 374\u2013380 (2013).","journal-title":"Comput. Phys. Commun."},{"key":"87535_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"87535_CR37","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller, B. R. et al. MMPBSA.py: An efficient program for end-state free energy calculations. J. Chem. Theory Comput. 8, 3314\u20133321 (2012).","journal-title":"J. Chem. Theory Comput."}],"updated-by":[{"DOI":"10.1038\/s41598-025-92778-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87535-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:25:44Z","timestamp":1741602344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87535-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87535"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87535-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-025-92778-z","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-92778-z","URL":"https:\/\/doi.org\/10.1038\/s41598-025-92778-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4146"}}